Distinguished in Thrombocytopenia

Michelle Sholzberg

St. Michael's Hospital Li Ka Shing Knowledge Institute
Toronto, ON, CA 
Distinguished in Thrombocytopenia
St. Michael's Hospital Li Ka Shing Knowledge Institute
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Michelle Sholzberg practices in Toronto, Canada. Ms. Sholzberg is rated as a Distinguished expert by MediFind in the treatment of Thrombocytopenia. Her top areas of expertise are Blood Clots, Iron Deficiency Anemia, Hemophilia A, Von Willebrand Disease (VWD), and Splenectomy.

Her clinical research consists of co-authoring 155 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 20 articles and participated in 2 clinical trials in the study of Thrombocytopenia.

Gender
Female

Locations

St. Michael's Hospital Li Ka Shing Knowledge Institute
Toronto, ON, Canada
Other Locations
St. Michael's Hospital, Canada
St. Michael's Hospital, London, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

ADVATE/ ADYNOVI Hemophilia A Outcome Database
ADVATE/ ADYNOVI Hemophilia A Outcome Database
Enrollment Status: Completed
Publish Date: June 17, 2024
Intervention Type: Biological
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug
Study Drug: Fostamatinib
Study Phase: Phase 3
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Enrollment Status: Completed
Publish Date: May 25, 2023
Intervention Type: Drug
Study Drug: Fostamatinib
Study Phase: Phase 3
Treatment of thromBocytopenia With EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients With Immune ThrombocytoPenia- BRIDGING ITP Study
Treatment of thromBocytopenia With EltRombopag or Intravenous Immune Globulin (IVIG) Before and DurING Invasive Procedures in Patients With Immune ThrombocytoPenia- BRIDGING ITP Study
Enrollment Status: Completed
Publish Date: September 09, 2020
Intervention Type: Drug
Study Phase: Phase 3
Elucidation of the Mechanism of IVIG-Associated Hemolysis
Elucidation of the Mechanism of IVIG-Associated Hemolysis
Enrollment Status: Completed
Publish Date: March 14, 2017
View 4 Less Clinical Trials

155 Total Publications

Title Not Found
Title Not Found
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: August 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sholzberg's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 30 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile